Clinical Trials

138 enrolled

Advanced/Metastatic Solid Tumors

NCT07480733 2026-03-18

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

480 enrolled

Advanced Malignant Solid Tumors

NCT07477886 2026-03-17

Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer

Not yet recruiting

134 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

42 enrolled

Advanced Solid Tumor Malignancies

NCT06771739 2026-03-13

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

20 enrolled

Malignant Solid Neoplasm

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

111 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07469982 2026-03-13

A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors

122 enrolled

Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion

NCT07467629 2026-03-12

QLS5212 for Participants With Advanced Solid Tumors

100 enrolled

Solid Tumor Cancer

NCT07459920 2026-03-10

CAPTURE

156 enrolled

Advanced Malignant Solid Tumor

NCT07459998 2026-03-10

SKB103 for Injection in Advanced Solid Tumors

277 enrolled

Advanced Solid Tumors

NCT07460375 2026-03-10

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

191 enrolled

Advanced Solid Tumors

NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

192 enrolled

Metastatic Solid Tumors

NCT07455734 2026-03-06

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

533 enrolled

Advanced Solid Tumor Cancer

NCT07450352 2026-03-04

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

150 enrolled

Unresectable Solid Tumors

NCT07362888 2026-03-03

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

180 enrolled

Solid Tumors (Phase 1)

NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

152 enrolled

Advanced Solid Tumor Cancer

NCT07446855 2026-03-03

PARTHENON

180 enrolled

Solid Tumours

NCT07443020 2026-03-02

RIOT 4B

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07176975 2026-02-27

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Phase 3 Not yet recruiting

Solid Tumors

NCT07412613 2026-02-27

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

386 enrolled

GastrointestinalOther solid neoplasm

Resectable Colon Cancer

NCT07436728 2026-02-27

A Study of TAK-505 in Adults With Solid Tumors

151 enrolled

Malignant Solid Tumors

NCT07437625 2026-02-27

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

90 enrolled

High-Burden Metastatic Solid Tumors

NCT07438093 2026-02-27

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

60 enrolled

Advanced Solid Tumors

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

150 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Advanced Solid Tumor (Phase 1)

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

24 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms

NCT06827054 2026-02-18

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

20 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

60 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Solid Tumors

NCT07412665 2026-02-17

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Advanced Solid Tumors

NCT07414836 2026-02-17

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

84 enrolled

Advanced Solid Tumor

NCT07415031 2026-02-17

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Solid Tumors

NCT07408258 2026-02-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT07407504 2026-02-12

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

186 enrolled

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

NCT07234058 2026-02-11

LAG-MAPS

Other solid neoplasmThoracic

126 enrolled

Mesothelioma, Malignant

NCT07390383 2026-02-09

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Advanced Solid Tumour

NCT07395258 2026-02-09

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

60 enrolled

Solid Tumors

NCT07396090 2026-02-09

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

13 enrolled

Advanced Solid Tumor

NCT07396584 2026-02-09

A Phase I/Ⅱa Study of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

186 enrolled

Solid Tumors, Adult

NCT07391644 2026-02-06

A Study of JSKN027 in Patients With Advanced Solid Tumors

250 enrolled

Advanced Malignant Solid Tumor

NCT07385950 2026-02-04

Evaluation of the Diagnostic Efficacy of a αvβ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors

Not yet recruiting

100 enrolled

PET / CT

NCT06772090 2026-02-03

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

40 enrolled

Solid Tumor, Adult

NCT07380334 2026-02-02

A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

200 enrolled

Advanced Solid Tumor

NCT07380386 2026-02-02

SKB105 for Injection in Advanced Solid Tumors

256 enrolled

Advanced Solid Tumors

NCT07363369 2026-01-23

Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

NCT07359820 2026-01-22

ReFocus202

30 enrolled

FGFR2 Gene Fusion/Rearrangement

NCT07348653 2026-01-21

A Study of MG2512 Injection in Participants With Advanced Solid Tumors

116 enrolled

Advanced Solid Tumor

NCT07356856 2026-01-21

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

Advanced and Relapsed Solid Tumors

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

30 enrolled

Solid Tumor, Adult

NCT07345637 2026-01-16

FXS887-I101

14 enrolled

Solid Tumor Refractory to Conventional Treatment

NCT07339748 2026-01-15

A Clinical Study of ZL-85FA Tablets

51 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Advanced Solid Tumor

NCT07325123 2026-01-08

Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors

30 enrolled